L
Lucid Diagnostics Inc
NASDAQ:LUCD
Lucid Diagnostics Inc
NASDAQ:LUCD
Price:
0.95 USD
8.11%
Market Closed
Updated:
May 3, 2024
Section:
Relative Value
The Relative Value of one LUCD stock under the Base Case scenario is 2.57 USD. Compared to the current market price of 0.95 USD, Lucid Diagnostics Inc is Undervalued by 63%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LUCD
Relative Value
Base Case
2.57
USD
Undervaluation 63%
L
Valuation Multiples
Multiples Across Competitors
LUCD Competitors Multiples
Lucid Diagnostics Inc Competitors
Lucid Diagnostics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
L
|
Lucid Diagnostics Inc
NASDAQ:LUCD
|
45.6m USD | 18.8 | -0.9 | -1.1 | -1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.7B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
134B USD | 18.3 | 67.4 | 55.3 | 69.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.3B USD | 5.9 | 37 | 24 | 29.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.6B USD | 3.3 | 25.6 | 13.6 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.2 | 59.8 | 30.5 | 45 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
69.4B USD | 3.6 | 57 | 19 | 40.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.6B EUR | 2.6 | 38 | 18.3 | 30.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.2B USD | 13.2 | 78.5 | 58.6 | 76.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
